Portal de Periódicos da CAPES

Toxicology in the Drug Discovery and Development Process

2006; Wiley; Volume: 32; Issue: 1 Linguagem: Inglês

10.1002/0471141755.ph1003s32

1934-8290

Michael A. Dorato, Lorrene A. Buckley,

Pharmaceutical studies and practices

Abstract The primary objective of toxicology studies in the drug development process is to evaluate the safety of potential drug candidates. This is accomplished using relevant animal models and validated procedures. The ultimate goal is to translate the animal model responses into an understanding of the risk for human subjects. To this end, the toxicologist must be aware of the international guidelines for safety evaluation, as well as traditional and nontraditional toxicology models. As described in this unit, the typical toxicology profile consists of safety pharmacology, genetic toxicology, acute and subchronic toxicology, chronic toxicology, absorption, distribution, metabolism, and excretion (ADME) studies, reproductive and developmental toxicology, and an evaluation of carcinogenic potential.